Orthotopic heart transplantation in a patient with persistent left superior vena cava.

Ann Thorac Cardiovasc Surg

Department of Cardiac Surgery, Heart Center, University of Heidelberg, Heidelberg, Germany.

Published: June 2013

We would like to discuss this rare case of an orthotopic heart transplantation in a recipient with an unknown history of persistent left superior vena cava.

Download full-text PDF

Source
http://dx.doi.org/10.5761/atcs.cr.11.01828DOI Listing

Publication Analysis

Top Keywords

orthotopic heart
8
heart transplantation
8
persistent left
8
left superior
8
superior vena
8
vena cava
8
transplantation patient
4
patient persistent
4
cava discuss
4
discuss rare
4

Similar Publications

This report describes the first long-term survival following a heart transplant for Williams syndrome-associated cardiac pathologies. An 11-year-old patient with severe global left ventricular dysfunction presented with heart failure and underwent heart transplantation. Her peri- and post-operative courses were complicated by hypertension related to underlying vascular pathology.

View Article and Find Full Text PDF

Heart transplantation: comparing the impact of modified heart preservation with conventional methods.

Sci Rep

January 2025

Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.

The purpose of this study was to compare the impact of modified heart preservation techniques with conventional heart preservation techniques on heart transplant recipients. The goal was to determine if these modified preservation techniques could extend the preservation of the donor heart without increasing the risk of recipient mortality. A retrospective analysis was carried out on 763 cases of orthotopic heart transplantation performed at Wuhan Union Hospital and Nanjing First Hospital, from September 2008 to October 2022.

View Article and Find Full Text PDF

Case Report: pericardial and sternal wound infection following orthotopic heart transplantation.

Front Cardiovasc Med

January 2025

Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC, United States.

, a genus of soil and vegetation-based fungi, is a rare cause of infections in immunocompromised individuals, including transplant recipients. In this case, we describe successful treatment of mediastinitis in the recipient of an orthotopic heart transplant. Treatment included multiple courses of combination antibiotic and antifungal therapy several surgical debridements, continuous mediastinal irrigation with antifungal agents, and staged closure with an omental flap.

View Article and Find Full Text PDF

Background: Metabolic syndrome represents a pancreatic ductal adenocarcinoma (PDAC) risk factor. Metabolic alterations favor PDAC onset, which occurs early upon dysmetabolism. Pancreatic neoplastic lesions evolve within a dense desmoplastic stroma, consisting in abundant extracellular matrix settled by cancer associated fibroblasts (CAFs).

View Article and Find Full Text PDF

Cardiac allograft vasculopathy (CAV) is a major prognosis-limiting factor in patients undergoing orthotopic heart transplantation (HT). Due to the diffuse involvement of the coronary tree, CAV lesions are often not amenable to percutaneous coronary intervention (PCI), leaving coronary artery bypass grafting (CABG) and retransplantation as primary revascularization options. : The latest guidelines from the International Society for Heart and Lung Transplantation (ISHLT) recognize CABG as a viable option but with a downgraded strength of recommendation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!